InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida. Show more

Location: 6303 Waterford District Drive, Miami, FL, 33126, United States | Website: https://www.inspiremd.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

72.3M

52 Wk Range

$1.99 - $3.80

Previous Close

$2.43

Open

$2.45

Volume

42,726

Day Range

$2.36 - $2.45

Enterprise Value

45.78M

Cash

26.09M

Avg Qtr Burn

-6.399M

Insider Ownership

28.43%

Institutional Own.

42.16%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date